Article
Skin cancer vaccine an 'exciting' advance in reducing risk of melanoma relapse, trial shows
Rating:
0.0
Views:
42
Likes:
1
Library:
1
Risk of melanoma skin cancer relapse was significantly reduced by a personalized mRNA cancer vaccine combined with immunotherapy, a clinical trial found.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value